SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-14-014627
Filing Date
2014-01-17
Accepted
2014-01-17 17:01:34
Documents
5
Period of Report
2014-01-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K d656485d8ka.htm 8-K/A 18790
2 EX-23.1 d656485dex231.htm EX-23.1 3599
3 EX-99.1 d656485dex991.htm EX-99.1 236036
4 EX-99.2 d656485dex992.htm EX-99.2 233981
5 EX-99.3 d656485dex993.htm EX-99.3 380470
  Complete submission text file 0001193125-14-014627.txt   873916
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35952 | Film No.: 14535733
SIC: 2834 Pharmaceutical Preparations